Table 3.

Correlations between different aPLs and clinical manifestations among APS patients (n = 151).

	Thrombosis	Arterial thrombosis	Venous thrombosis		Pregnancy morbidity	Pregnancy loss	TP	Microangiopathy	Stroke	LA
aCL IgG	1.3 (0.6–3.1)	1.6 (0.8–3.2)	0.8 (0.4–1.6)	1.2 (0.6–2.7)		1.0 (0.5–2.3)	1.3 (0.7–2.6)	1.3 (0.6–2.4)	2.1 (0.8–5.5)	9.0* (2.6–31.0)
aCL IgM	0.6 (0.2–1.9)	0.8 (0.3–2.7)	0.7 (0.2–2.3)	1.0 (0.3–3.5)		0.5 (0.1–2.1)	1.6 (0.5–4.9)	0.5 (0.2–1.6)	1.3 (0.3–6.3)	3.9 (0.5–31.3)
aCL IgA	0.6 (0.2–1.2)	0.8 (0.4–1.5)	0.8 (0.4–1.5)	0.9 (0.4–1.9)		1.5 (0.7–3.2)	0.8 (0.4–1.5)	0.6 (0.3–1.2)	1.8 (0.7–4.8)	1.2 (0.5–2.5)
aβ2GPI IgG	1.7 (0.6–5.0)	1.6 (0.8–3.4)	1.0 (0.5–2.1)	1.1 (0.5–2.9)		0.9 (0.4–2.4)	1.3 (0.6–2.8)	1.4 (0.6–3.0)	2.8* (1.0–7.7)	14.1* (1.9–107.2)
aβ2GPI IgM	1.3 (0.3–6.5)	0.4 (0.1–1.6)	2.5 (0.7–8.6)	0.9 (0.2–4.2)		0.6 (0.1–3.0)	1.9 (0.6–6.3)	1.2 (0.4–4.1)	2.5 (0.6–10.5)	1.5 (0.3–7.5)
aβ2GPI IgA	1.1 (0.2–5.2)	0.9 (0.2–3.3)	1.8 (0.5–6.7)	1.0 (1.0–1.1)		0.7 (0.2–3.0)	0.8 (0.2–3.1)	0.6 (0.2–1.0)	0.8 (0.1–6.4)	2.9 (0.4–23.4)
aPS/PT IgG	1.3 (0.4–3.6)	1.7 (0.8–4.0)	0.7 (0.3–1.6)	1.3 (0.5–3.4)		0.9 (0.3–2.6)	1.1 (0.5–2.6)	1.4 (0.6–3.3)	3.1* (1.1–8.7)	4.7* (1.1–21.2)
aPS/PT IgM	1.2 (0.2–5.8)	0.8 (0.2–2.7)	2.1 (0.6–7.6)	0.4 (0.1–2.0)		0.6* (0.5–0.7)	1.6 (0.5–5.5)	0.3 (0.1–1.2)	0.7 (0.1–5.6)	3.2 (0.4–26.0)
aAnxV IgG	1.7 (0.7–4.3)	1.8 (0.9–3.6)	0.8 (0.4–1.7)	1.0 (0.4–2.3)		0.7 (0.3–1.7)	1.9 (0.9–3.7)	1.5 (0.8–3.1)	2.3 (0.9–6.1)	21.5* (2.8–163.0)
aAnxV IgM	1.1 (0.4–3.1)	1.3 (0.6–3.1)	0.7 (0.3–1.8)	1.0 (0.3–2.6)		0.9 (0.3–2.6)	1.8 (0.8–4.3)	1.4 (0.6–3.3)	2.7 (0.9–8.1)	2.5 (0.7–8.9)
LA	4.0* (1.7–9.5)	1.3 (0.6–2.9)	2.7* (1.2–6.1)	0.5 (0.2–1.1)		0.9 (0.4–2.2)	4.1* (1.7–10.2)	1.5 (0.7–3.2)	1.7* (1.5–6.2)	–

Odds ratios (ORs) with 95% confidence intervals (CIs) are shown. *p < 0.05.